Form D · Other Health Care
Evergreen Nephrology LLC
Nashville, TN · CIK 0001930772
Offering snapshot reported Jun 6, 2022 · SEC filing
- Reported sold
- $4.34M Offering amount: $10M
- Investors reported
- 335 Form D · investor count
- Minimum accepted
- $1K Reported outside-investor minimum
- First sale
- May 22, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 6, 2022 | Initial | $4,335,000 | No comparison | 335 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-448224
Source: Form D, filed Jun 6, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Arjun Aggarwal | Director |
| Adam Boehler | Director |
| Eric Jenkins | Executive |
| Matt Kim | Director |
| Annie Lamont | Director |
| Scott Lloyd | Executive |
| Abe Sutton | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
210 Athens Way, Suite 200
Nashville, TN, 37208
Nashville, TN, 37208